IGF2 and Beckwith-Wiedemann syndrome: It would be of interest for future studies to examine the effects of somatic tissue reprogramming at the IC1 and IC2 DMRs from BWS patients harbouring epimutations, such as a GOM at the maternal H19/IGF2:IG-DMRDMR.